1. Home
  2. SHCO vs NUVB Comparison

SHCO vs NUVB Comparison

Compare SHCO & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHCO
  • NUVB
  • Stock Information
  • Founded
  • SHCO 1995
  • NUVB 2018
  • Country
  • SHCO United Kingdom
  • NUVB United States
  • Employees
  • SHCO N/A
  • NUVB N/A
  • Industry
  • SHCO Hotels/Resorts
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHCO Consumer Discretionary
  • NUVB Health Care
  • Exchange
  • SHCO Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • SHCO 1.0B
  • NUVB 837.0M
  • IPO Year
  • SHCO 2021
  • NUVB N/A
  • Fundamental
  • Price
  • SHCO $6.32
  • NUVB $2.23
  • Analyst Decision
  • SHCO Buy
  • NUVB Strong Buy
  • Analyst Count
  • SHCO 2
  • NUVB 6
  • Target Price
  • SHCO $7.25
  • NUVB $7.83
  • AVG Volume (30 Days)
  • SHCO 292.2K
  • NUVB 5.0M
  • Earning Date
  • SHCO 08-12-2025
  • NUVB 08-07-2025
  • Dividend Yield
  • SHCO N/A
  • NUVB N/A
  • EPS Growth
  • SHCO N/A
  • NUVB N/A
  • EPS
  • SHCO N/A
  • NUVB N/A
  • Revenue
  • SHCO $1,224,734,000.00
  • NUVB $10,957,000.00
  • Revenue This Year
  • SHCO $8.99
  • NUVB $98.78
  • Revenue Next Year
  • SHCO $6.02
  • NUVB $489.71
  • P/E Ratio
  • SHCO N/A
  • NUVB N/A
  • Revenue Growth
  • SHCO 8.21
  • NUVB N/A
  • 52 Week Low
  • SHCO $4.43
  • NUVB $1.54
  • 52 Week High
  • SHCO $8.47
  • NUVB $3.83
  • Technical
  • Relative Strength Index (RSI)
  • SHCO 36.53
  • NUVB 46.97
  • Support Level
  • SHCO $6.30
  • NUVB $2.46
  • Resistance Level
  • SHCO $6.58
  • NUVB $2.76
  • Average True Range (ATR)
  • SHCO 0.26
  • NUVB 0.15
  • MACD
  • SHCO -0.06
  • NUVB -0.01
  • Stochastic Oscillator
  • SHCO 19.42
  • NUVB 21.32

About SHCO Soho House & Co Inc.

Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: